RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-1139
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1141300; Gene model (P.falciparum): PF3D7_1365500; Gene product: aminomethyltransferase, mitochondrial, putative | glycine cleavage system T protein, putative (GCVT)
PhenotypeNo phenotype has been described
Last modified: 5 December 2014, 10:24
  *RMgm-1139
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption
Reference (PubMed-PMID number) Reference 1 (PMID number) : 25454081
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherVaradarajan NM; Nagaraj VA
Name Group/DepartmentDepartment of Biochemistry
Name InstituteIndian Institute of Science
CityBangalore
CountryIndia
Name of the mutant parasite
RMgm numberRMgm-1139
Principal namePbTKO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageNot different from wild type
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of glycine cleavage T protein, putative

Protein (function)
The biosynthesis of the active folate factor - N5, N10 - methylenetetrahydrofolate (CH2-THF) that is required for the synthesis of thymidylate and  methionine involves the activities of serine hydroxymethyltransferase (SHMT) and glycine  cleavage system (GCS/GCV; glycine decarboxylase complex).
GCS represents the multi-enzyme complex composed of four proteins namely, P-, H-, T- and L-protein catalyzing the reversible oxidative decarboxylation of glycine to yield carbon dioxide,  ammonia, CH2-THF and reduced nicotinamide adenine dinucleotide.
T-protein, an aminomethyltransferase, represents one of the four components of glycine  cleavage system (GCS) and catalyzes the transfer of methylene group from H-protein intermediate to tetrahydrofolate (THF) forming N5, N10-methylene THF (CH2-THF) with the  release of ammonia. The malaria parasite genome encodes T- (PF3D7_1365500;PBANKA_114130), H- (PF3D7_1132900;PBANKA_091550) and L-proteins (isoform 1: PF3D7_1232200;PBANKA_144690; isoform 2: PF3D7_0815900; PBANKA_071490), but not P-protein which is a glycine decarboxylase generating the aminomethylene group. A putative  GCS has been considered to be functional in the parasite mitochondrion despite the absence of a detectable P-protein homologue.

Phenotype
Phenotype analyses of the knockout mtant indicate that the T-proteins does not play an essential role throughout the life cycle. No phenotypes were detected that were different from wild type parasites.

Additional information
Evidence is presented for a mitochondrial localisation of T-protein in blood stages of both P. falciparum and P. berghei (using antobodies and immunofluorescence analysis).

No detailed information is provided on the generation of the construct. No information is provided for primers (sequence) used to amplify the 3'and 5'UTR target regions.

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1141300
Gene Model P. falciparum ortholog PF3D7_1365500
Gene productaminomethyltransferase, mitochondrial, putative | glycine cleavage system T protein, putative
Gene product: Alternative nameGCVT
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Click to view information
Click to hide information
No detailed information is provided on the generation of the construct. No information is provided for primers (sequence) used to amplify the 3'and 5'UTR target regions.
Restriction sites to linearize plasmid
Partial or complete disruption of the genePartial
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationNo detailed information is provided on the No detailed information is provided on the generation of the construct. No information is provided for primers (sequence) used to amplify the 3'and 5'UTR target regions.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6